Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Pfizer Inc
Deal Size : $1,549.0 million
Deal Type : Collaboration
TRIANA and Pfizer Partner to Discover Novel Molecular Glue Degraders
Details : The collaboration aims to discover novel molecular glue degraders for multiple targets in several disease areas, including oncology.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : $49.0 million
October 15, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Pfizer Inc
Deal Size : $1,549.0 million
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?